Psoriasiform skin lesion and supprative acrodermatitis associated with Kawasaki disease followed by the treatment with infliximab: A case report

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 7, 2010, Pages 1102-1104

  Kishimoto, S ^a   Muneuchi, J ^a   Takahashi, Y ^a   Izu, K ^a   Nakano, R ^a   Joo, K ^a  

^a KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Coronary artery aneurysm; Hyperkeratosis; Infliximab; Kawasaki disease; Psoriasis

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE; STEROID;

ACRODERMATITIS; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; CORTICOSTEROID THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

ACRODERMATITIS; ANTIBODIES, MONOCLONAL; FOREARM; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PSORIASIS;

EID: 77953177754     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01745.x     Document Type: Article

References (10)

1. Mizuno Y, Suga Y, Muramatsu S, Hasegawa T, Ogawa H. Psoriasiform and palmoplanter pustular lesions induced after Kawasaki disease. Int J Dermatol 2006 45 : 1080 1082.
2. Zvulunov A, Greenberg D, Cagnano E, Einhorn M. Development of psoriatic lesions during acute and convalescent phases of Kawasaki disease. J Paediatr Child Health 2003 39 : 229 231.
3. Eberhard BA, Sundel RP, Newburger JW, Baker A, Fuhlbrigge RC, Burns JC, Gellis SE. Psoriatic eruption in Kawasaki disease. J Pediatr 2000 137 : 578 580.
4. Tsai HJ, Wu WM, Chang YC, Wang CM, Hong HS. Annular pustules in Kawasaki disease: a further case indicating the association with psoriasis? Cutis 2003 72 : 354 356.
5. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998 4 : 78 83.
6. Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008 9 : 1 14.
7. Hirono K, Kemmotsu Y, Wittkowski H, Foell D, Saito K, Ibuki K, et al. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease. Pediatr Res 2009 65 : 696 701.
8. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005 146 : 662 667.
9. Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 2008 153 : 833 838.
10. Day R. Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis. Lancet 2002 359 : 540 541.